Jazz Pharmaceuticals plc buy Truist Financial Co.
Start price
04.12.23
/
50%
€112.25
Target price
04.12.24
€184.92
Performance (%)
-13.84%
Price
03.06.24
€97.02
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.84%. This prediction currently runs until 04.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | -0.736% | -0.736% |
iShares Core DAX® | -0.552% | 3.281% |
iShares Nasdaq 100 | -1.415% | 4.535% |
iShares Nikkei 225® | -0.877% | -1.739% |
iShares S&P 500 | -0.415% | 3.239% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€115.00
20.03.24
20.03.24
€184.14
20.03.25
20.03.25
-15.63%
03.06.24
03.06.24